Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics …
S Lu, X Liu, C Wu, J Zhang, A Stalin, Z Huang, Y Tan… - Medicine, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) is one of the most malignant tumors with a poor prognosis.
The long non-coding RNA (lncRNA) has been found to have great potential as a prognostic …
The long non-coding RNA (lncRNA) has been found to have great potential as a prognostic …
Construction of an immune-related six-lncRNA signature to predict the outcomes, immune cell infiltration, and immunotherapy response in patients with hepatocellular …
P Zhou, Y Lu, Y Zhang, L Wang - Frontiers in oncology, 2021 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is one of the world's most lethal malignant
tumors with a poor prognosis. Growing evidence has been demonstrating that immune …
tumors with a poor prognosis. Growing evidence has been demonstrating that immune …
Four immune-related long non-coding RNAs for prognosis prediction in patients with hepatocellular carcinoma
M Li, M Liang, T Lan, X Wu, W Xie, T Wang… - Frontiers in Molecular …, 2020 - frontiersin.org
Background Long non-coding RNA (LncRNA) plays an important role in the occurrence and
development of hepatocellular carcinoma (HCC). This study aims to establish an immune …
development of hepatocellular carcinoma (HCC). This study aims to establish an immune …
Immune-related lncRNA pairs clinical prognosis model construction for hepatocellular carcinoma
Y Zhu, D Shan, L Guo, S Chen, X Li - International Journal of …, 2022 - Taylor & Francis
Background Long non-coding RNA (lncRNA) plays an essential regulatory role in the
occurrence and development of hepatocellular carcinoma (HCC). This paper aims to …
occurrence and development of hepatocellular carcinoma (HCC). This paper aims to …
Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
M Deng, JB Lin, RC Zhao, SH Li, WP Lin, JW Zou… - BMC cancer, 2021 - Springer
Background The accuracy of existing biomarkers for predicting the prognosis of
hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that …
hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that …
Identification of a Nine Immune‐Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma
M Yuan, Y Wang, Q Sun, S Liu, S Xian… - BioMed Research …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) ranks fifth among common cancers and is the second most
common cause of cancer‐related mortality worldwide. This study is aimed at identifying an …
common cause of cancer‐related mortality worldwide. This study is aimed at identifying an …
Bioinformatics profiling of five immune-related lncRNAs for a prognostic model of hepatocellular carcinoma
F Wu, H Wei, G Liu, Y Zhang - Frontiers in oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC), one of the most common tumors worldwide, has the fifth
highest mortality rate, which is increasing every year. At present, many studies have …
highest mortality rate, which is increasing every year. At present, many studies have …
Bioinformatics Analysis for Constructing a Six‐Immune‐Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular Carcinoma
J Wang, Z Jin, G Wu, J Wang, B Xu… - BioMed Research …, 2022 - Wiley Online Library
The present study was aimed at identifying the potential prognostic biomarkers of the
immune‐related long noncoding RNA (IRL) signature for patients with hepatocellular …
immune‐related long noncoding RNA (IRL) signature for patients with hepatocellular …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Identification of novel tumor microenvironment-related long noncoding RNAs to determine the prognosis and response to immunotherapy of hepatocellular carcinoma …
S Huang, J Zhang, X Lai, L Zhuang… - Frontiers in molecular …, 2021 - frontiersin.org
Introduction: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
with poor prognosis. The tumor microenvironment (TME) plays a vital role in HCC …
with poor prognosis. The tumor microenvironment (TME) plays a vital role in HCC …
相关搜索
- lncrna signature hepatocellular carcinoma
- bioinformatics analysis hepatocellular carcinoma
- bioinformatics analysis prognostic prediction
- prognostic prediction hepatocellular carcinoma
- bioinformatics analysis rna signature
- cell infiltration hepatocellular carcinoma
- comprehensive analysis immune microenvironment
- immune status lncrna signature
- immune microenvironment hepatocellular carcinoma
- immunotherapy response hepatocellular carcinoma
- experimental validation hepatocellular carcinoma
- rna signature hepatocellular carcinoma
- comprehensive analysis hepatocellular carcinoma
- lncrna pairs hepatocellular carcinoma
- bioinformatics profiling hepatocellular carcinoma
- immune status hepatocellular carcinoma